Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

DelMar Pharmaceuticals goes public through reverse merger

Executive Summary

Cancer therapeutics developer DelMar Pharmaceuticals BC Ltd. has reverse merged with public shell company Berry Only Inc., which changed its name to DelMar Pharmaceuticals Inc. for the purpose of the acquisition. The new parent, DelMar Pharmaceuticals Inc., will trade on the OTC Bulletin Board under the symbol DMPI.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Reverse Acquisition

Related Companies